News from qrxpharma limited

Jul 11, 2014, 09:00 ET

QRxPharma Provides Feedback On End-of-Review Meeting With The FDA On Moxduo®

 QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) today provided feedback on its 9 July End-of-Review (EOR) meeting with the United States Food...

Jul 09, 2014, 09:02 ET

QRxPharma Announces Board Resignations

 QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today that Chairman, Dr. Peter Farrell and Director, Dr. Gary Pace have resigned from...

May 27, 2014, 06:00 ET

QRxPharma Receives Complete Response Letter From FDA Regarding Moxduo® NDA

QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today the United States Food and Drug...

May 01, 2014, 22:00 ET

Dr. Edward Rudnic Appointed CEO of QRxPharma

QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today that Dr. John Holaday has stepped down as Managing Director and Chief Executive...

Mar 24, 2014, 08:00 ET

FDA Sets 22 April 2014 For Moxduo® Advisory Committee Meeting

 QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today the United States Food and Drug Administration (FDA) has set 22 April 2014 as...

Dec 13, 2013, 09:00 ET

QRxPharma Completes A$11.6 Million Capital Raising

 QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) today announced the successful completion of its Share Purchase Plan (SPP) to existing...

Dec 11, 2013, 09:00 ET

QRxPharma Announces 25 May 2014 as New PDUFA Date for MOXDUO® NDA

 QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today that the United States Food and Drug Administration (FDA) has established 25 May...

Nov 26, 2013, 09:00 ET

QRxPharma Refiles MOXDUO® New Drug Application with the FDA

QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today that the Company resubmitted its MOXDUO® New Drug Application (NDA). At a...

Nov 13, 2013, 09:00 ET

QRxPharma Announces Successful Completion Of A$7.5 Million Placement

QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) ("QRxPharma") announced today the successful completion of a Placement to institutional and...

Oct 15, 2013, 09:00 ET

QRxPharma Extends MOXDUO® License With Aspen

QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today the execution of a licensing agreement with Aspen Pharmacare Holdings Limited (JSE:...

Oct 09, 2013, 09:00 ET

QRxPharma Reports Positive Meeting With The FDA On MOXDUO®

 QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today the results of its meeting on October 3 with the United States Food and Drug...

Sep 11, 2013, 09:00 ET

QRxPharma Announces MOXDUO® License With Aspen

 QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today execution of a licensing agreement with Aspen Pharma Pty Ltd, one of the...

Sep 06, 2013, 09:00 ET

FDA Schedules Review Meeting With QRxPharma Regarding MOXDUO® NDA

QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today the United States Food and Drug Administration (FDA) has scheduled a meeting on 3...

Jul 22, 2013, 07:00 ET

QRxPharma Announces Collaboration With Aesica

QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today execution of a Collaboration Agreement with Aesica Formulation Development Limited, a...

Jun 26, 2013, 09:14 ET

QRxPharma Updates MOXDUO® NDA Review

QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today the planned 17 July 2013 US Food and Drug Administration (FDA) Advisory...

Jun 12, 2013, 09:00 ET

QRxPharma Granted US Patent On Hybrid Opioids

 QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today that the United States Patent and Trademark Office (USPTO) issued the...

May 17, 2013, 09:00 ET

FDA Sets 17 July 2013 For MOXDUO® Advisory Committee Meeting

 QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today the US Food and Drug Administration (FDA) has set 17 July 2013 as the date of...

Mar 14, 2013, 09:00 ET

FDA Sets 26 August 2013 As New PDUFA Date For MOXDUO® NDA

 QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today the US Food and Drug Administration (FDA) has set 26 August 2013 as the...

Feb 28, 2013, 09:00 ET

QRxPharma Resubmits MOXDUO® New Drug Application to the FDA

 QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today that the Company resubmitted its MOXDUO® New Drug Application (NDA). As...

Jan 16, 2013, 08:00 ET

QRxPharma and FDA Establish Path Forward for Resubmission Of MOXDUO® New Drug Application

QRxPharma Limited (ASX: QRX and OTCQX: QRXPY) announced today that the steps necessary for approval of immediate release MOXDUO have been clarified...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

Research and Markets
Analysts Review
ReportBuyer